Who invested in Black Diamon Therapeutics?
Black Diamon Therapeutics's investors include Boxer Capital, Deerfield, Janus Henderson Investors, Casdin Capital and BVF Partners, and 2 more on record. Boxer Capital led its latest round.
United States · Series C startup
One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$85Mraised across 1 round since 2019, from 1 source
Reported by FinSMEs
Black Diamon Therapeutics's investors include Boxer Capital, Deerfield, Janus Henderson Investors, Casdin Capital and BVF Partners, and 2 more on record. Boxer Capital led its latest round.
Black Diamon Therapeutics has raised $85M across 1 round since 2019.
Black Diamon Therapeutics's most recent round was a Series C of $85M in Dec 2019, led by Boxer Capital.
Its most recent round, $85M in Dec 2019, is also its largest on record.
Black Diamon Therapeutics's first round on record, in Dec 2019, was backed by Boxer Capital, Deerfield and Janus Henderson Investors and 4 others.
Black Diamon Therapeutics's latest named round is a Series C, in Dec 2019.
Black Diamon Therapeutics is based in the United States.
Boxer Capital led the Series C in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.